PUBLICATION

The inhibition of protein translation promotes tumor angiogenic switch

Authors
Luo, H., Shen, Y., Liao, W., Li, Q., Wu, N., Zhong, J., Xiao, C., Gan, J., Yang, Y., Dong, E., Zhang, G., Liu, B., Yue, X., Xu, L., Liu, Y., Zhao, C., Zhong, Q., Yang, H.
ID
ZDB-PUB-220614-13
Date
2022
Source
Molecular biomedicine   3: 18 (Journal)
Registered Authors
Keywords
Angiogenic switch, HIF, Microtumor, Protein translation, Vegfa
MeSH Terms
none
PubMed
35695994 Full text @ Mol Biomed
Abstract
The 'angiogenic switch' is critical for tumor progression. However, the pathological details and molecular mechanisms remain incompletely characterized. In this study, we established mammal xenografts in zebrafish to visually investigate the first vessel growth (angiogenic switch) in real-time, by inoculating tumor cells into the perivitelline space of live optically transparent Transgenic (flk1:EGFP) zebrafish larvae. Using this model, we found that hypoxia and hypoxia-inducible factor (HIF) signaling were unnecessary for the angiogenic switch, whereas vascular endothelial growth factor A gene (Vegfa) played a crucial role. Mechanistically, transcriptome analysis showed that the angiogenic switch was characterized by inhibition of translation, but not hypoxia. Phosphorylation of eukaryotic translation initiation factor 2 alpha (Eif2α) and the expression of Vegfa were increased in the angiogenic switch microtumors, and 3D tumor spheroids, and puromycin-treated tumor cells. Vegfa overexpression promoted early onset of the angiogenic switch, whereas Vegfa knockout prevented the first tumor vessel from sprouting. Pretreatment of tumor cells with puromycin promoted the angiogenic switch in vivo similarly to Vegfa overexpression, whereas Vegfa knockdown suppressed the increase. This study provides direc and dynamic in vivo evidences that inhibition of translation, but not hypoxia or HIF signaling promotes the angiogenic switch in tumor by increasing Vegfa transcription.
Genes / Markers
Figures
Show all Figures
Expression
Phenotype
Mutations / Transgenics
Human Disease / Model
Sequence Targeting Reagents
Fish
Antibodies
Orthology
Engineered Foreign Genes
Mapping